Neogen Corp. (NASDAQ: NEOG) reported Q2 EPS of $0.31, $0.01 better than the analyst estimate of $0.30. Revenue for the quarter came in at $107.1 million versus the consensus estimate of $108.87 million.

"We are generally pleased with our operational performance, considering the continued sluggish animal protein markets and currency headwinds we faced in the quarter," said John Adent, Neogen\'s president and chief executive officer. "When we consider the tremendous opportunities that exist for Neogen outside of the United States, we are willing to accept the occasional bump in the road from adverse currency conversions. In the quarter, we had a number of strong performances in sales of recently commercialized products, especially in our foodborne pathogen and natural toxin product lines."

For earnings history and earnings-related data on Neogen Corp. (NEOG) click here.